(Q33437197)

26 July 2017

Detection of serum MMP-7 and MMP-9 in cholangiocarcinoma patients: evaluation of diagnostic accuracy (English)

1 reference

26 July 2017

0 references

Kawin Leelawat

1

1 reference

26 July 2017

Sompong Sakchinabut

series ordinal

2

1 reference

26 July 2017

Siriluck Narong

series ordinal

3

1 reference

26 July 2017

Jerasak Wannaprasert

series ordinal

4

1 reference

26 July 2017

30 April 2009

1 reference

26 July 2017

1 reference

26 July 2017

9

1 reference

26 July 2017

30

1 reference

Creative Commons Attribution 2.0 Generic

26 July 2017

start time

30 April 2009

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

exact match

https://scigraph.springernature.com/pub.10.1186/1471-230x-9-30

0 references

cites work

Diagnosis of cholangiocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Elevation of carbohydrate antigen 19.9 in benign hepatobiliary conditions and its correlation with serum bilirubin concentration.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Cholangiocarcinoma: lessons from Thailand

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Hilar cholangiocarcinoma: diagnosis and staging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Identification of pro-MMP-7 as a serum marker for renal cell carcinoma by use of proteomic analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Liver fluke induces cholangiocarcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Serum and bile markers for cholangiocarcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Matrix metalloproteinases: multifunctional contributors to tumor progression

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Measurement of matrix metalloproteinases and tissue inhibitors of metalloproteinases in blood and tissues. Clinical and experimental applications

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Immunohistochemical analysis of the progression of flat and papillary preneoplastic lesions in intrahepatic cholangiocarcinogenesis in hepatolithiasis.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-30

Expression of matrix metalloproteinase-2 and -9 and tissue inhibitor of metalloproteinase-1 and -2 in intraductal and nonintraductal growth type of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-30

Prognostic significance of MMP-9 and TIMP-1 serum and tissue expression in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-30

Preanalytical conditions and circulating matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-30

Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-9-30

[Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma].

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Mirizzi syndrome with cholecysto-choledocal fistula with a high CA19-9 level mimicking biliary malignancies: a case report

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2680894

Serum matrix metalloproteinase 7 levels identifies poor prognosis advanced colorectal cancer patients

31 October 2018

1 reference

12 December 2020

Relation of matrix metalloproteinase-9 to different stages of tumors in the serum of gastric cancer

1 reference

12 December 2020

Expression of matrix metalloproteinase 7 is an unfavorable postoperative prognostic factor in cholangiocarcinoma of the perihilar, hilar, and extrahepatic bile ducts

1 reference

12 December 2020

Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma

1 reference

12 December 2020

High lifetime risk of cancer in primary sclerosing cholangitis

1 reference

12 December 2020

Clinical significance of serum MMP-2 and MMP-7 in patients with ovarian cancer

1 reference

12 December 2020

1 reference

12 December 2020

Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma

1 reference

12 December 2020

Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ?

1 reference

12 December 2020

Primary sclerosing cholangitis

1 reference

12 December 2020

Matrix metalloproteinase-9 (MMP-9) elevated in serum but not in bronchial lavage fluid in patients with lung cancer

1 reference

12 December 2020

The diagnostic value of the measurement of matrix metalloproteinase 9 (MMP-9), squamous cell cancer antigen (SCC) and carcinoembryonic antigen (CEA) in the sera of esophageal cancer patients

1 reference

12 December 2020

Diagnostic role of serum CA 19-9 for cholangiocarcinoma in patients with primary sclerosing cholangitis

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-230X-9-30

1 reference

26 July 2017

1 reference

26 July 2017

1 reference